Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions

Yoshie Sugiura, Chien Ping Ko

Research output: Contribution to journal › Article

41 Citations (Scopus)

Abstract

This study aimed to examine changes of presynaptic voltage-sensitive calcium channel (VSCC) subtypes during synapse formation and regeneration in relation to transmitter release at the neuromuscular junction (NMJ). Synaptic potentials were recorded from developing rat NMJs and from regenerating mouse and frog NMJs. As in normal adult NMJs, evoked transmitter release was reduced by an N-type VSCC blocker in the frog and by a P/Q-type VSCC blocker in the mammal at immature NMJs; however, various L-type VSCC blockers, both dihydropyridine and nondihydropyridine antagonists, increased evoked but not spontaneous release in a dose-dependent manner at newly formed NMJs. This presynaptic potentiation disappeared as NMJs matured. A rapid intracellular Ca2+ buffer, bis(O-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-AM, prevented the potentiation effect of nifedipine, but a slow Ca2+ buffer, EGTA-AM, did not. Thus, the potentiation effect of L-type blockers requires Ca2+ transients. Pretreatment with Ca2+-activated K+ channel blockers, iberiotoxin or chary odotoxin, did not prevent potentiation by nifedipine at regenerating frog NMJs. Thus, Ca2+-activated K+ channels were not likely involved in this potentiation. In contrast, no additional potentiation by nifedipine was seen in muscles pretreated with pertussis toxin (PTX), a G- protein blocker, which by itself enhances evoked transmitter release at regenerating frog NMJs. These results suggest the existence of multiple subtypes of VSCCs at newly formed motor nerve terminals. In addition to the normal N- or P/Q-type VSCCs that mediate transmitter release, L-type VSCCs may play a novel modulatory role in evoked transmitter release by activating a mechanism linked to PTX-sensitive G-proteins during synapse maturation.

Original languageEnglish (US)
Pages (from-to)1101-1111
Number of pages11
JournalJournal of Neuroscience
Volume17
Issue number3
StatePublished - 1997

Fingerprint

L-Type Calcium Channels
Neuromuscular Junction
Anura
Calcium Channel Blockers
Nifedipine
Calcium-Activated Potassium Channels
Pertussis Toxin
GTP-Binding Proteins
Synapses
Buffers
Synaptic Potentials
Ethane
Calcium Channels
Acetic Acid
Regeneration
Mammals
Muscles

Keywords

  • dihydropyridine
  • neuromuscular junctions
  • PTX-sensitive G-proteins synapse formation
  • transmitter release
  • voltage-sensitive calcium channels

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions. / Sugiura, Yoshie; Ko, Chien Ping.

In: Journal of Neuroscience, Vol. 17, No. 3, 1997, p. 1101-1111.

Research output: Contribution to journal › Article

Sugiura, Y & Ko, CP 1997, 'Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions', Journal of Neuroscience, vol. 17, no. 3, pp. 1101-1111.
Sugiura Y, Ko CP. Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions. Journal of Neuroscience. 1997;17(3):1101-1111.
Sugiura, Yoshie ; Ko, Chien Ping. / Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions. In: Journal of Neuroscience. 1997 ; Vol. 17, No. 3. pp. 1101-1111.
@article{1c174079cb3b4bd1aaa23e3406684927,
title = "Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions",
abstract = "This study aimed to examine changes of presynaptic voltage-sensitive calcium channel (VSCC) subtypes during synapse formation and regeneration in relation to transmitter release at the neuromuscular junction (NMJ). Synaptic potentials were recorded from developing rat NMJs and from regenerating mouse and frog NMJs. As in normal adult NMJs, evoked transmitter release was reduced by an N-type VSCC blocker in the frog and by a P/Q-type VSCC blocker in the mammal at immature NMJs; however, various L-type VSCC blockers, both dihydropyridine and nondihydropyridine antagonists, increased evoked but not spontaneous release in a dose-dependent manner at newly formed NMJs. This presynaptic potentiation disappeared as NMJs matured. A rapid intracellular Ca2+ buffer, bis(O-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-AM, prevented the potentiation effect of nifedipine, but a slow Ca2+ buffer, EGTA-AM, did not. Thus, the potentiation effect of L-type blockers requires Ca2+ transients. Pretreatment with Ca2+-activated K+ channel blockers, iberiotoxin or chary odotoxin, did not prevent potentiation by nifedipine at regenerating frog NMJs. Thus, Ca2+-activated K+ channels were not likely involved in this potentiation. In contrast, no additional potentiation by nifedipine was seen in muscles pretreated with pertussis toxin (PTX), a G- protein blocker, which by itself enhances evoked transmitter release at regenerating frog NMJs. These results suggest the existence of multiple subtypes of VSCCs at newly formed motor nerve terminals. In addition to the normal N- or P/Q-type VSCCs that mediate transmitter release, L-type VSCCs may play a novel modulatory role in evoked transmitter release by activating a mechanism linked to PTX-sensitive G-proteins during synapse maturation.",
keywords = "dihydropyridine, neuromuscular junctions, PTX-sensitive G-proteins synapse formation, transmitter release, voltage-sensitive calcium channels",
author = "Yoshie Sugiura and Ko, {Chien Ping}",
year = "1997",
language = "English (US)",
volume = "17",
pages = "1101--1111",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "3",

}

TY - JOUR

T1 - Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions

AU - Sugiura, Yoshie

AU - Ko, Chien Ping

PY - 1997

Y1 - 1997

N2 - This study aimed to examine changes of presynaptic voltage-sensitive calcium channel (VSCC) subtypes during synapse formation and regeneration in relation to transmitter release at the neuromuscular junction (NMJ). Synaptic potentials were recorded from developing rat NMJs and from regenerating mouse and frog NMJs. As in normal adult NMJs, evoked transmitter release was reduced by an N-type VSCC blocker in the frog and by a P/Q-type VSCC blocker in the mammal at immature NMJs; however, various L-type VSCC blockers, both dihydropyridine and nondihydropyridine antagonists, increased evoked but not spontaneous release in a dose-dependent manner at newly formed NMJs. This presynaptic potentiation disappeared as NMJs matured. A rapid intracellular Ca2+ buffer, bis(O-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-AM, prevented the potentiation effect of nifedipine, but a slow Ca2+ buffer, EGTA-AM, did not. Thus, the potentiation effect of L-type blockers requires Ca2+ transients. Pretreatment with Ca2+-activated K+ channel blockers, iberiotoxin or chary odotoxin, did not prevent potentiation by nifedipine at regenerating frog NMJs. Thus, Ca2+-activated K+ channels were not likely involved in this potentiation. In contrast, no additional potentiation by nifedipine was seen in muscles pretreated with pertussis toxin (PTX), a G- protein blocker, which by itself enhances evoked transmitter release at regenerating frog NMJs. These results suggest the existence of multiple subtypes of VSCCs at newly formed motor nerve terminals. In addition to the normal N- or P/Q-type VSCCs that mediate transmitter release, L-type VSCCs may play a novel modulatory role in evoked transmitter release by activating a mechanism linked to PTX-sensitive G-proteins during synapse maturation.

AB - This study aimed to examine changes of presynaptic voltage-sensitive calcium channel (VSCC) subtypes during synapse formation and regeneration in relation to transmitter release at the neuromuscular junction (NMJ). Synaptic potentials were recorded from developing rat NMJs and from regenerating mouse and frog NMJs. As in normal adult NMJs, evoked transmitter release was reduced by an N-type VSCC blocker in the frog and by a P/Q-type VSCC blocker in the mammal at immature NMJs; however, various L-type VSCC blockers, both dihydropyridine and nondihydropyridine antagonists, increased evoked but not spontaneous release in a dose-dependent manner at newly formed NMJs. This presynaptic potentiation disappeared as NMJs matured. A rapid intracellular Ca2+ buffer, bis(O-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-AM, prevented the potentiation effect of nifedipine, but a slow Ca2+ buffer, EGTA-AM, did not. Thus, the potentiation effect of L-type blockers requires Ca2+ transients. Pretreatment with Ca2+-activated K+ channel blockers, iberiotoxin or chary odotoxin, did not prevent potentiation by nifedipine at regenerating frog NMJs. Thus, Ca2+-activated K+ channels were not likely involved in this potentiation. In contrast, no additional potentiation by nifedipine was seen in muscles pretreated with pertussis toxin (PTX), a G- protein blocker, which by itself enhances evoked transmitter release at regenerating frog NMJs. These results suggest the existence of multiple subtypes of VSCCs at newly formed motor nerve terminals. In addition to the normal N- or P/Q-type VSCCs that mediate transmitter release, L-type VSCCs may play a novel modulatory role in evoked transmitter release by activating a mechanism linked to PTX-sensitive G-proteins during synapse maturation.

KW - dihydropyridine

KW - neuromuscular junctions

KW - PTX-sensitive G-proteins synapse formation

KW - transmitter release

KW - voltage-sensitive calcium channels

UR - http://www.scopus.com/inward/record.url?scp=0031021031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031021031&partnerID=8YFLogxK

M3 - Article

C2 - 8994064

AN - SCOPUS:0031021031

VL - 17

SP - 1101

EP - 1111

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 3

ER -

Access to Document